Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Biotech
AbbVie-bound Cerevel reports phase 3 Parkinson's victory
The backing singer in AbbVie’s $8.7 billion takeover of Cerevel Therapeutics is having its moment in the spotlight.
Nick Paul Taylor
Apr 18, 2024 8:34am
Pulmocide exits OPERA with evidence of antifungal efficacy
Apr 15, 2024 9:41am
Neumora schizophrenia drug on FDA hold over rabbit convulsions
Apr 15, 2024 9:00am
MaaT posts 18-month data showing 'clear OS advantage' in aGvHD
Apr 15, 2024 7:05am
Enlivex defends sepsis data that sank stock
Apr 12, 2024 9:30am
Amylyx stock slips 6% after phase 2 rare disease data drop
Apr 10, 2024 2:48pm